Hans Tesch
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Viral-associated cancers and disorders
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 199
- Cancer Treatment and Pharmacology 66
- HER2/EGFR in Cancer Research 63
-
- Advanced Breast Cancer Therapies 73
- Lung Cancer Treatments and Mutations 29
- Co-authors
- Volker Diehl (90 shared papers)Dieter Kube (21 shared papers)Heribert Bohlen (26 shared papers)Sibylle Loibl (62 shared papers)Jens Huober (53 shared papers)Gϋnter von Minckwitz (47 shared papers)Michael Untch (52 shared papers)Peter A. Fasching (66 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Cancer Research (34 papers)Annals of Oncology (34 papers)Blood (13 papers)European Journal of Cancer (12 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hans Tesch
331 papers receiving 9.3k citations
Hans Tesch's Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 5.3k
- Cancer Research 2.7k
- Pathology and Forensic Medicine 2.8k
- Genetics 985
- Immunology 1.8k
Countries citing papers authored by Hans Tesch
This map shows the geographic impact of Hans Tesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Tesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Tesch more than expected).
Fields of papers citing papers by Hans Tesch
This network shows the impact of papers produced by Hans Tesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Tesch. The network helps show where Hans Tesch may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Tesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease Hit paper breakdown → | 2003 | 538 |
| 2 | Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients Hit paper breakdown → | 2014 | 472 |
| 3 | 2010 | 402 | |
| 4 | 2010 | 398 | |
| 5 | 1997 | 310 | |
| 6 | 2012 | 297 | |
| 7 | 2010 | 220 | |
| 8 | 1995 | 195 | |
| 9 | 2000 | 176 | |
| 10 | 2013 | 172 | |
| 11 | 2001 | 172 | |
| 12 | 2000 | 168 | |
| 13 | 2007 | 162 | |
| 14 | 2001 | 160 | |
| 15 | 2010 | 155 | |
| 16 | 2016 | 149 | |
| 17 | 2001 | 131 | |
| 18 | 1997 | 110 | |
| 19 | 2013 | 105 | |
| 20 | 1997 | 104 |
About Hans Tesch
Hans Tesch is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 346 papers that have together received 9.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (94 papers), Advanced Breast Cancer Therapies (73 papers), Lymphoma Diagnosis and Treatment (69 papers), Cancer Treatment and Pharmacology (66 papers), HER2/EGFR in Cancer Research (63 papers), Monoclonal and Polyclonal Antibodies Research (45 papers), Chronic Lymphocytic Leukemia Research (35 papers) and Lung Cancer Treatments and Mutations (29 papers). The work is most often cited by research in Oncology (5.3k citations), Cancer Research (2.7k citations), Pathology and Forensic Medicine (2.8k citations), Genetics (985 citations) and Immunology (1.8k citations). Hans Tesch has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Diehl, Dieter Kube, Heribert Bohlen, Sibylle Loibl, Jens Huober, Gϋnter von Minckwitz, Michael Untch, Peter A. Fasching, Jeremy Franklin and Holger Eidtmann. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Blood and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.